GANX Stock Price Prediction

Gain Therapeutics Inc

Add to Watchlist

Advanced Chart

1.840

-0.12(-6.122%)1D

Should I Buy Gain Therapeutics Inc Stock?

Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. GANX has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.

GANX stock price ended at $1.84 on Monday, after losing -6.12%

The Gain Therapeutics Inc stock price decreased by -6.12% on the last trading day (03 Nov 2025), dropping from 1.99 to 1.84. Throughout the last trading session, the stock experienced a fluctuation of 13.97% , ranging from a day low of $1.79 to a day high of 2.04. The price has declined in 7 of the last 10 days, resulting in a total change of -4.17% during this period. On the last day, trading volume increase by -250.25K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 888.57K shares were traded, amounting to approximately 1.73M.

GANX Technical Signals

GANX(Gain Therapeutics Inc Corp) has 2 buy signals and 5 sell signals now. The current trend is an uptrend starting from 2025-10-30. The total price change during this trend is +4.55%. Recently, the price has dropped while volume droped, indicating a potential rebound signal. The average turnover of GANX over the last 5 trading days is 1.42M. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.

GANX Moving Average Analysis

Gain Therapeutics Inc's overall moving average trend leans more bearish as of Tuesday, November 4, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $2.17, and $2.31. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $1.70, and $1.55. A break-down below any of these levels will issue sell signals.

GANX Short Selling Analysis

The short sale ratio of Gain Therapeutics Inc(GANX) as of 31 Oct 2025 is 16.50%, dropping from last trading day. With decreasing price from 1.76 to 1.96. The short sell activity indicate that short sellers may be experiencing short cover.

Technical Signal

Technical Signals Summary

Sell

Buy

Moving Average

Swing

Negative

Stock Price Below SMA_5

Short Term

Negative

SMA_5 Below SMA_20

Mid Term

Positive

SMA_20 Above SMA_60

Long Term

Negative

SMA_60 Below SMA_200

Short Selling

Close Price

Short Sale Ratio

Short Sale Volume

2 Bullish Signals

When Value satisfies Signal, Indicator signals Bullish

Indicators

Signal

Value

Meaning

Awesome Oscillator (5, 34)

AO_5_34 > 0

0.00128

Bullish

Moving Average Convergence Divergence (12, 26, 9)

MACD_12_26_9 > 0

0.00667

Bullish

5 Bearish Signals

When Value satisfies Signal, Indicator signals Bearish

Indicators

Signal

Value

Meaning

Momentum (10 days)

MOM_10 < 0

-0.08

Bearish

Moving Average

Price crosses below 5-day SMA

Bearish

Moving Average

Price crosses below 10-day SMA

Bearish

Moving Average

Price crosses below 200-day SMA

Bearish

Moving Average

Price crosses below 250-day SMA

Bearish

GANX Stock Forecast

2026

2027

2028

2029

2030

2031

2032

2033

2034

2035

Month	Min. Price	Avg. Price	Max. Price	Potential ROI
Month	Min. Price	Avg. Price	Max. Price	Potential ROI
No data

Unlock Free Stock Price Forecast

In 2026, Gain Therapeutics Inc (GANX) is anticipated to change hands in a trading channel between $0.00 and $0.00.

Gain Therapeutics Inc Stock Forecast 2026

GANX Price Prediction & Forecast by Similar Chart Analysis

Based on historical patterns and backtesting of stocks with similar movements to Gain Therapeutics Inc(GANX), our algorithm predicts GANX's 1-month price at $3.71, with an 89.53%upwardshift. Using a similarity score up to 90.87%and other factors, This forecast updates weekly, adjusting for significant deviations.

Similar Chart

The price prediction chart for Gain Therapeutics Inc (GANX.O) stock, as of Sunday, November 2, 2025 , forecasts a 89.53% change over the next month, based on its high correlation with HOUR.O stock patterns. The similarity between their price movements over the analyzed periods is 90.87%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

GANX

Future prediction

Up: 89.53%

Full Access. No Commitment.

7 Days Free!

AI Stock Picker

AI Swing Trade Signal

AI Earning Prediction

AI Screener

AI Financial Agent Help You Do Research

GET STARTED!

Already have an account? Sign In Here

HOUR

Up: 89.53%Similarity: 90.87%

Name

Similarity

Up/Down

HOUR.O

90.87%

+89.53%

DJCO.O

90.76%

-3.32%

GANX Seasonality Analysis

Based on GANX's historical stock price data across all years, the probability of a positive return in November is20.00%, suggesting it maynotbe an ideal month to invest in GANX. In contrast,Decemberoffers the highest probability of positive returns at75.00%, making it a potentially strong month for investment.

However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.

Monthly Seasonality

The radar chart shows that buying Gain Therapeutics Inc (GANX.O) stock in December has the highest probability of a positive return (75.00%), while May has the lowest probability (0.00%).

Performance Seasonality

The chart shows Gain Therapeutics Inc. (GANX)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.